Practical Guidance on Optimizing CLL Care in the Era of Molecular Therapies

Download these slides to review the most recent clinical data on new agents in both frontline and relapsed/refractory CLL.
Emily Bucholtz Headshot
Emily Bucholtz, RPh
Nichole Fisher Headshot
Nichole Fisher, RN, BSN
Jeff P. Sharman, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.29 MB
Released: July 17, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
CLL Society Logo
Supported by educational grants from
AbbVie
AstraZeneca
Pharmacyclics LLC, An AbbVie Company
Verastem Oncology

Related Content

This downloadable resource includes a proposed 2019 treatment algorithm for myeloma and a list of key ongoing or enrolling clinical trials for patients with myeloma

Ajai Chari, MD Released: August 22, 2019

John M. Burke, MD, and Shaji Kumar, MD, discuss practice-changing presentations in lymphomas, CLL, and multiple myeloma from ASCO 2019.

John M. Burke, MD Shaji Kumar, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: August 16, 2019 Expiration: August 15, 2020

Noopur Raje, MD: Clinical impact of latest data for idecabtagene vicleucel (bb2121) and other CAR T-cells in relapsed/refractory multiple myeloma.

Noopur Raje, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 16, 2019 Expiration: August 15, 2020

Expert insights from Alessandra Tedeschi, MD, on new data for B-cell malignancy management reported at the 2019 EHA and ICML meetings

person default Alessandra Tedeschi, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: August 13, 2019 Expiration: August 12, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?